Yunkang Group (HKSE:02325) EV-to-EBIT : -129.00 (As of Jun. 07, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Yunkang Group's Enterprise Value is HK$6,102.6 Mil. Yunkang Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-47.3 Mil. Therefore, Yunkang Group's EV-to-EBIT for today is -129.00.

The historical rank and industry rank for Yunkang Group's EV-to-EBIT or its related term are showing as below:

HKSE:02325' s EV-to-EBIT Range Over the Past 10 Years
Min: -139.69 Med: 14.16 Max: 19.14
Current: -129

During the past 6 years, the highest EV-to-EBIT of Yunkang Group was 19.14. The lowest was -139.69. And the median was 14.16.

HKSE:02325's EV-to-EBIT is ranked worse than
100% of 97 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.36 vs HKSE:02325: -129.00

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Yunkang Group's Enterprise Value for the quarter that ended in Dec. 2023 was HK$6,938.1 Mil. Yunkang Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-47.3 Mil. Yunkang Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -0.68%.

Yunkang Group EV-to-EBIT Historical Data

The historical data trend for Yunkang Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group EV-to-EBIT Chart

Yunkang Group Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

17.98

-146.66

Yunkang Group Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial				-	-	17.98	-	-146.66

Competitive Comparison of Yunkang Group's EV-to-EBIT

For the Diagnostics & Research subindustry, Yunkang Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yunkang Group's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Yunkang Group's EV-to-EBIT falls into.

Yunkang Group EV-to-EBIT Calculation

Yunkang Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	6102.563	/	-47.307
	=	-129.00

Yunkang Group's current Enterprise Value is HK$6,102.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yunkang Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-47.3 Mil.

Yunkang Group (HKSE:02325) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Yunkang Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-47.307	/	6938.0737
	=	-0.68 %

Yunkang Group's Enterprise Value for the quarter that ended in Dec. 2023 was HK$6,938.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yunkang Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-47.3 Mil.

Yunkang Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Yunkang Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Yunkang Group (HKSE:02325) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN

Website

http://www.yunkanghealth.com

Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.

Executives

Huizekx Limited	2201 Interest of corporation controlled by you
Yk Development Limited	2101 Beneficial owner
Zhang Yong	2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd	2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si	2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Jin Jun Ying Limited	2201 Interest of corporation controlled by you
Mouduans Limited	2201 Interest of corporation controlled by you
Source Capital Rw Limited	2201 Interest of corporation controlled by you
Tongfuzc Limited	2201 Interest of corporation controlled by you
Wjjr Investment Limited	2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines